The High-Touch Challenge
While specialty drugs have been available for several decades, the rapid growth in both the quantity and cost of these drugs over the last few years has put specialty drug therapies in the spotlight.
As specialty drugs increase in prevalence, the specialty pharmacy may turn out to be at the very center of the accountable care movement. New reimbursement models tied to improving outcomes are emerging, and these may help to offset the continual decline in pharmacy margins.
However, accountable care organizations and insurers focused on the cost and performance of specialty drugs expect pharmacies to deliver high-touch services that deliver positive outcomes. While many specialty pharmacies are eager to attract new business, providing cost-effective services that meet increased expectations for patient care is a challenge.